Person profile
Roles
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CODEXIS, INC.
13 Jun 24
4
SANGAMO THERAPEUTICS, INC
6 Jun 24
4
CODEXIS, INC.
15 Jun 23
4
SANGAMO THERAPEUTICS, INC
5 Jun 23
4
CODEXIS, INC.
20 Dec 22
3
CODEXIS, INC.
20 Dec 22
4
IMPEL PHARMACEUTICALS INC
17 Jun 22
4
SANGAMO THERAPEUTICS, INC
3 Jun 22
4
SANGAMO THERAPEUTICS, INC
1 Mar 22
4
IMPEL NEUROPHARMA INC
13 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Jun 24 | CDXS Codexis | Common Stock | Grant | Acquire A | No | No | 0 | 30,120 | 0.00 | 102,600 |
4 Jun 24 | SGMO Sangamo Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 87,600 |
4 Jun 24 | SGMO Sangamo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5676 | 50,000 | 28.38 k | 50,000 |
13 Jun 23 | CDXS Codexis | Common Stock | Grant | Acquire A | No | No | 0 | 34,602 | 0.00 | 72,480 |
1 Jun 23 | SGMO Sangamo Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 13,900 | 0.00 | 62,600 |
1 Jun 23 | SGMO Sangamo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.11 | 27,750 | 30.80 k | 27,750 |